Immunocore Holdings plc (IMCR) FY2026 Q2 Balance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
Immunocore Holdings plc (IMCR) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$235.20 MLiabilities$699.62 MCurrent assets$1.05 BNon-current liabilities$464.43 MAssets$1.12 BEquity$419.80 MGross equity(calculated)$1.27 BNon-current assets$68.38 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSCash and cash equivalentsMarketable securitiesAccounts receivable, netPrepaid expenses and other current assetsInventory, netOperating lease right of use assets, netOther non-current assetsProperty and equipment, netAccrued expenses and other current liabilitiesAccounts payableOperating lease liabilities, currentDeferred revenue, currentInterest-bearing loans and borrowingsOperating lease liabilities, non-currentAccrued expenses, non-currentDeferred revenue, non-currentAdditional paid-in capitalOrdinary shares (voting), £0.002 par value, most recent authority to allot up to a maximum nominal value of £149,303 and £149,633 shares as of June 30, 2026 and December 31, 2025, respectively, and 51,480,159 and 50,689,271 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively.Deferred shares, £0.0001 par value, 5,793,501 shares authorized, issued and outstanding as of June 30, 2026 and December 31, 2025.Current assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Accumulated deficitAccumulated other comprehensive lossCurrent liabilitiesCurrent liabilities$235.20 MAccrued expenses and other current liabilitiesAccrued expenses and other current liabilities$206.40 MAccounts payableAccounts payable$26.32 MLiabilitiesLiabilities$699.62 MOperating lease liabilities, currentOperating lease liabilities, current$1.91 MDeferred revenue, currentDeferred revenue, current$573.00 KCurrent assetsCurrent assets$1.05 BNon-current liabilitiesNon-current liabilities$464.43 MCash and cash equivalentsCash and cash equivalents$484.92 MInterest-bearing loans and borrowingsInterest-bearing loans and borrowings$394.21 MAssetsAssets$1.12 BOperating lease liabilities, non-currentOperating lease liabilities, non-current$38.85 MAccrued expenses, non-currentAccrued expenses, non-current$26.88 MMarketable securitiesMarketable securities$395.29 MEquityEquity$419.80 MDeferred revenue, non-currentDeferred revenue, non-current$4.49 MGross equity (calculated)Gross equity(calculated)$1.27 BAccounts receivable, netAccounts receivable, net$95.35 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$67.69 MInventory, netInventory, net$7.79 MOperating lease right of use assets, netOperating lease right of use assets, net$37.02 MNon-current assetsNon-current assets$68.38 MAdditional paid-in capitalAdditional paid-in capital$1.27 BOther non-current assetsOther non-current assets$18.50 MProperty and equipment, netProperty and equipment, net$12.86 MOrdinary shares (voting), £0.002 par value, most recent authority to allot up to a maximum nominal value of £149,303 and £149,633 shares as of June 30, 2026 and December 31, 2025, respectively, and 51,480,159 and 50,689,271 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively.Ordinary shares (voting)$138.00 KDeferred shares, £0.0001 par value, 5,793,501 shares authorized, issued and outstanding as of June 30, 2026 and December 31, 2025.Deferred shares$1.00 KAccumulated deficitAccumulated deficit−$819.11 MAccumulated other comprehensive lossAccumulated other comprehensive loss−$34.33 M
Chart details

Immunocore Holdings plc (IMCR) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
1,119,422,000 US dollars
Current assets
1,051,044,000 US dollars
Non-current assets
68,378,000 US dollars
Liabilities
699,624,000 US dollars
Current liabilities
235,198,000 US dollars
Non-current liabilities
464,426,000 US dollars
Equity
419,798,000 US dollars
Cash and cash equivalents
484,920,000 US dollars
Marketable securities
395,291,000 US dollars
Accounts receivable, net
95,350,000 US dollars
Prepaid expenses and other current assets
67,692,000 US dollars
Inventory, net
7,791,000 US dollars
Operating lease right of use assets, net
37,020,000 US dollars
Other non-current assets
18,495,000 US dollars
Property and equipment, net
12,863,000 US dollars
Accrued expenses and other current liabilities
206,400,000 US dollars
Accounts payable
26,319,000 US dollars
Operating lease liabilities, current
1,906,000 US dollars
Deferred revenue, current
573,000 US dollars
Interest-bearing loans and borrowings
394,206,000 US dollars
Operating lease liabilities, non-current
38,847,000 US dollars
Accrued expenses, non-current
26,883,000 US dollars
Deferred revenue, non-current
4,490,000 US dollars
Additional paid-in capital
1,273,101,000 US dollars
Ordinary shares (voting), £0.002 par value, most recent authority to allot up to a maximum nominal value of £149,303 and £149,633 shares as of June 30, 2026 and December 31, 2025, respectively, and 51,480,159 and 50,689,271 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively.
138,000 US dollars
Deferred shares, £0.0001 par value, 5,793,501 shares authorized, issued and outstanding as of June 30, 2026 and December 31, 2025.
1,000 US dollars
Accumulated deficit
negative 819,112,000 US dollars
Accumulated other comprehensive loss
negative 34,330,000 US dollars
Gross equity (calculated)
1,273,240,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
Immunocore Holdings plc (IMCR) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!